½ÃÀ庸°í¼­
»óǰÄÚµå
1486454

¼¼°èÀÇ ¼Ö¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå ±Ô¸ð Á¶»ç : Àç·áº°, Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)

Global Intramedullary Nails Market Size study, by Material, By Product Type, By Application, By End-user and Regional Forecasts 2022-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Àü ¼¼°è ¼Ö¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀåÀº 2023³â ¾à 10¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇß°í, ¿¹Ãø ±â°£ÀÎ 2024³âºÎÅÍ 2032³â±îÁö 5.72% ÀÌ»óÀÇ °ß½ÇÇÑ ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¤Çü¿Ü°ú¿¡¼­´Â »ó¿Ï°ñ, °æ°ñ, ´ëÅð°ñ°ú °°Àº Àå°ñ °ñÀý¿¡ ´ëóÇϱâ À§ÇØ °ñ¼ö ³» ¸øÀ» »ç¿ëÇÕ´Ï´Ù. °ñ¼ö°­¿¡ »ðÀÔµÈ ÀÌ ¸øÀº °ñÀýµÈ »À Á¶°¢À» ¾ÈÁ¤½Ã۰í Á¤·ÄÇÏ¿© Ä¡À¯¸¦ ÃËÁøÇÏ°í ±â´ÉÀ» ȸº¹½ÃŰ´Â ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀϹÝÀûÀ¸·Î ƼŸ´½À̳ª ½ºÅ×Àθ®½º ½ºÆ¿°ú °°Àº ±Ý¼ÓÀ¸·Î ¸¸µé¾îÁö¸ç, »ÀÀÇ Å©±â¿Í °ñÀý À¯Çü¿¡ µû¶ó ´Ù¾çÇÑ ±æÀÌ¿Í Á÷°æÀÇ Á¦Ç°ÀÌ ÀÖ½À´Ï´Ù. ÀÏ´Ü »ðÀԵǸé, °ñ³» ¸øÀº ³»ºÎÀûÀ¸·Î °íÁ¤µÇ¾î »À¸¦ ÁöÁöÇϰí ÃÖÀûÀÇ Ä¡À¯¸¦ À§ÇÑ ÁÁÀº Á¶°ÇÀ» ¸¸µé¾î ÁÝ´Ï´Ù. ÀÌ ¹æ¹ýÀº ±âÁ¸ÀÇ ¼®°í³ª ¿Ü°íÁ¤ ¹æ¹ýÀ¸·Î´Â ³Ê¹« ºÒ¾ÈÁ¤ÇÑ °ñÀý¿¡ ÀÚÁÖ »ç¿ëµË´Ï´Ù. ô¼ö°­ ³» ¸ø ¹Ú±â´Â Ä¡À¯¸¦ ÃËÁøÇϰí, ºÒÆíÇÔÀ» ÃÖ¼ÒÈ­Çϸç, »çÁö¸¦ Á¶±â¿¡ ¿òÁ÷ÀÏ ¼ö ÀÖ°Ô ÇÔÀ¸·Î½á Á¤Çü¿Ü°úÀû °ñÀý °ü¸®¿¡¼­ ¸Å¿ì Áß¿äÇÑ ±â¼ú·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù. Á¦Á¶¾÷üµéÀº ½ºÅ×Àθ®½º ½ºÆ¿°ú °°Àº ±âÁ¸ ¼ÒÀç¿¡ ºñÇØ °­µµ, »ýüÀûÇÕ¼º, ³»½Ä¼ºÀÌ ¿ì¼öÇÑ Æ¼Å¸´½ Çձݰú °°Àº ¼ÒÀ縦 »ç¿ëÇÑ °ñ³»¸ø °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ã·´Ü ¼ÒÀç´Â ÀÓÇöõÆ® ¼ö¸íÀ» ¿¬ÀåÇÏ°í ºÎÀÛ¿ë°ú ÇÕº´Áõ À§ÇèÀ» °¨¼Ò½Ãŵ´Ï´Ù. µû¶ó¼­ ¼ö¼ú °á°ú¿Í ȯÀÚ °æÇèÀ» °³¼±Çϱâ À§ÇÑ Ã·´Ü Àç·á¿Í ±â¼úÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¼¼°è ô¼ö°­ ³» ³×ÀÏ ½ÃÀåÀÇ ¼ºÀå¿¡ Áß¿äÇÑ Æ®·»µå°¡ µÇ°í ÀÖ½À´Ï´Ù.

¼¼°è °ñ³» ³×ÀÏ ½ÃÀåÀÇ ¼ºÀåÀº °ñ³» ³×ÀÏ Ç÷¹ÀÌÆ®°¡ Á¦°øÇÏ´Â ÀÌÁ¡ Áõ°¡, ´Ù¾çÇÑ Å©±âÀÇ °ñ³» ¼ÕÅéÀÇ ´Ù¾çÇÑ ±¸»ö Áõ°¡, À¯¸®ÇÑ ÀÇ·á »óȯ Á¤Ã¥, ¾î¸°ÀÌÀÇ ´ëÅð°ñ, »ó¿Ï°ñ ¹× °æ°ñ¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¼±Ãµ¼º ±âÇüÀÇ ¹ß»ý Áõ°¡¿Í °°Àº ÁÖ¿ä ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ´ëÅð°ñ, °æ°ñ, »ó¿Ï°ñ°ú °°Àº Àå°ñÀÇ °ñÀýÀ» Æ÷ÇÔÇÑ Á¤Çü¿Ü°úÀû ¼Õ»óÀÇ À¯º´·ü Áõ°¡´Â °ñ³»¸ø ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â±¸´Â ÀÌ·¯ÇÑ °ñÀýÀ» ¾ÈÁ¤½Ã۰í Ä¡À¯¸¦ ÃËÁøÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ¶ÇÇÑ, ³ëÀÎ Àα¸ Áõ°¡´Â ô¼ö°­ ³» ³×ÀÏ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, MRI ¹× CT ½ºÄµ¿¡ ÀûÇÕÇÑ Ã´¼ö°­ ³» ¸ø ½ÃÀå °³Ã´ÀÌ ÁøÇàµÇ°í ÀÖ´Â °Íµµ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·°ú ´ëü Ä¡·á ¿É¼ÇÀÇ °¡¿ë¼ºÀº 2022³âºÎÅÍ 2032³â±îÁö ½ÃÀå ¼ºÀåÀ» ¾ïÁ¦ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è ô¼ö°­ ³» ³×ÀÏ ½ÃÀå Á¶»ç¿¡¼­ ÁÖ¿ä Áö¿ªÀ¸·Î´Â ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä« ¹× ±âŸ Áö¿ªÀÌ Æ÷ÇԵǸç, 2023³â ºÏ¹Ì´Â ô¼ö°­ ³» ³×ÀÏ ¼ö¿ä ±ÞÁõ, Á¤Çü¿Ü°úÀû ¿Ü»ó Áõ°¡ ¹× Á¤Çü¿Ü°úÀû ÀÓÇöõÆ® º¸±ÞÀ¸·Î ÀÎÇØ ô¼ö°­ ³» ³×ÀÏ ¼¼°è ½ÃÀå¿¡¼­ ½ÃÀå ¼öÀÍÀÇ ¼±µÎ ÀÚ¸®¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÃÀå ¼öÀÍ¿¡¼­ ¼±µÎ¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¸¹Àº Á¤Çü¿Ü°ú ¿Ü»ó ¹× Àç°Ç ±â±â ȸ»çµéÀÌ ÀÌ Áö¿ªÀÇ ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀο¡ ÈûÀÔ¾î ¼º°ú¸¦ °ÅµÎ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹¿¡ º»»ç¸¦ µÐ Globus Medical, Inc.´Â 82°³ ÀÌ»óÀÇ FDA Á¦Ç° ½ÂÀÎÀ» ȹµæÇß½À´Ï´Ù. ¶ÇÇÑ, Á¤ºÎ ±â°ü°ú ¹Î°£ ´Üü °£ÀÇ Çù·Â °ü°è Áõ°¡´Â ½ÃÀå È®´ë¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 10¿ù, ¹Ì±¹¿¡ º»»ç¸¦ µÐ ¼Õ ¼ö¼ú¿ë Á¤Çü¿Ü°ú ¼Ö·ç¼ÇÀ» Àü¹®À¸·Î ÇÏ´Â ºñ»óÀå ÀÇ·á±â±â ±â¾÷ ExsoMed CorporationÀº 10,000°ÇÀÇ Áß¼ö°ñ °ñÀýÀÌ Innate ô¼ö°­ ³» ³ª»ç¸øÀ¸·Î ¼º°øÀûÀ¸·Î Ä¡·áµÇ¾ú½À´Ï´Ù°í ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ ¼º°ú´Â Áß¼ö°ñ °ñÀýÀÇ ÃÖ¼Ò Ä§½ÀÀû °íÁ¤¿¡ »ç¿ëÇϵµ·Ï ¼³°èµÈ INnate NailÀ» ÅëÇØ ´Þ¼ºÇÑ Äè°Å´Ù.

ÀÌ º¸°í¼­¿¡ Æ÷ÇÔµÈ ÁÖ¿ä ½ÃÀå ±â¾÷Àº ´ÙÀ½°ú °°½À´Ï´Ù.
  • B. Braun Melsungen AG(µ¶ÀÏ)
  • Orthofix Holdings, Inc.
  • Advanced Orthopaedic Solutions(¹Ì±¹)
  • Stryker(¹Ì±¹)
  • Smith Nephew(¿µ±¹)
  • Aysam Ortopedi & Tibbi Cihazlar(ÅÍŰ)
  • Wright Medical Group N.V.(³×´ú¶õµå)
  • Zimmer Biomet(¹Ì±¹)
  • Johnson & Johnson Inc.
  • Pega Medical Inc(ij³ª´Ù)

¸ñÂ÷

Á¦1Àå ¼¼°èÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå Á¤ÀÇ¿Í Á¶»çÀÇ ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ½ÃÀåÀÇ Á¤ÀÇ
  • Á¶»çÀÇ ÀüÁ¦Á¶°Ç
    • Æ÷ÇÔ »çÇ× ¹× Á¦¿Ü »çÇ×
    • Á¦ÇÑ »çÇ×
    • °ø±ÞÃø ºÐ¼®
      • °¡¿ë¼º
      • ÀÎÇÁ¶ó
      • ±ÔÁ¦ ȯ°æ
      • ½ÃÀå °æÀï
      • °æÁ¦¼º(¼ÒºñÀÚ ½ÃÁ¡)
    • ¼ö¿äÃø ºÐ¼®
      • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
      • ±â¼ú Áøº¸
      • ģȯ°æ
      • ¼ÒºñÀÚ Àǽİú ¼ö¿ë
  • Á¶»ç ¹æ¹ý
  • Á¶»ç ´ë»ó³âµµ
  • ÅëÈ­ ȯ»êÀ²

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ¼¼°èÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2022-2032³â)
  • Áö¿ªº° °³¿ä
  • ºÎ¹®º° °³¿ä
    • Àç·áº°
    • Á¦Ç° À¯Çüº°
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
  • ÁÖ¿ä µ¿Çâ
  • ºÒȲÀÇ ¿µÇâ
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È

Á¦3Àå ¼¼°èÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
  • ½ÃÀå ±âȸ

Á¦4Àå ¼¼°èÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ¹ÙÀ̾îÀÇ ±³¼··Â
    • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
    • Porter's Five Forces ¸ðµ¨¿¡ ´ëÇÑ ¹Ì·¡Àû Á¢±Ù
    • Porter's Five ForcesÀÇ ¿µÇ⠺м®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ °ßÇØ
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È

Á¦5Àå ¼¼°èÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Àç·áº°, 2022-2032³â

  • ½ºÅ×Àθ®½º ½ºÆ¿
  • ƼŸ´½

Á¦6Àå ¼¼°èÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Á¦Ç° À¯Çüº°, 2022-2032³â

  • »óÁö »À
  • ÇÏÁö »À

Á¦7Àå ¼¼°èÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ¿ëµµº°, 2022-2032³â

  • ´ëÅð°ñ °ñ¼ö°­³» ±Ý¼ÓÁ¤
  • °æ°ñ °ñ¼ö°­³» ±Ý¼ÓÁ¤
  • °¨¸¶ °ñ¼ö°­³» ±Ý¼ÓÁ¤
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°, 2022-2032³â

  • º´¿ø
  • Àü¹® Ŭ¸®´Ð
  • ±âŸ

Á¦9Àå ¼¼°èÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°, 2022-2032³â

  • ºÏ¹ÌÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå
    • ¹Ì±¹
      • Àç·á ³»¿ª ±Ô¸ð¿Í ¿¹Ãø, 2022-2032³â
      • Á¦Ç° À¯Çü ³»¿ª ±Ô¸ð¿Í ¿¹Ãø, 2022-2032³â
      • ¿ëµµ ³»¿ª ±Ô¸ð¿Í ¿¹Ãø, 2022-2032³â
      • ÃÖÁ¾»ç¿ëÀÚ ³»¿ª ±Ô¸ð¿Í ¿¹Ãø, 2022-2032³â
    • ij³ª´ÙÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå
  • À¯·´ÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå
    • ¿µ±¹ÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå
    • µ¶ÀÏÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå
    • ÇÁ¶û½ºÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå
    • ½ºÆäÀÎÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå
    • ÀÌÅ»¸®¾ÆÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå
    • ±âŸ À¯·´ÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå
    • Áß±¹ÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå
    • ÀεµÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå
    • ÀϺ»ÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå
    • È£ÁÖÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå
    • Çѱ¹ÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå
    • ±âŸÀÇ ¾Æ½Ã¾ÆÅÂÆò¾ç °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå
    • ºê¶óÁúÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå
    • ¸ß½ÃÄÚÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå
    • »ç¿ìµð¾Æ¶óºñ¾ÆÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹ÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå

Á¦10Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • B. Braun Melsungen AG(Germany)
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍ ÀÔ¼ö°¡ °¡´ÉÇÑ °æ¿ì)
      • Á¦Ç° °³¿ä
      • ½ÃÀå Àü·«
    • Orthofix Holdings, Inc.(United States)
    • Advanced Orthopaedic Solutions(United States)
    • Stryker(United States)
    • Smith+Nephew(United Kingdom)
    • Aysam Ortopedi & Tibbi Cihazlar(Turkey)
    • Wright Medical Group N.V.(Netherlands)
    • Zimmer Biomet(United States)
    • Johnson & Johnson Inc.(United States)
    • Pega Medical Inc(Canada)

Á¦11Àå Á¶»ç °úÁ¤

  • Á¶»ç °úÁ¤
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»ç ¼Ó¼º
LSH 24.06.04

Global Intramedullary Nails Market is valued approximately at USD 1.02 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.72% over the forecast period 2024-2032. In orthopedic surgery, intramedullary nails are utilized to address long bone fractures in areas like the humerus, tibia, and femur. These nails, inserted into the bone's marrow cavity, serve to stabilize and realign fractured bone fragments, promoting healing and restoring function. Typically made of metals such as titanium or stainless steel, they come in various lengths and diameters to suit different bone sizes and fracture types. Once implanted, intramedullary nails provide internal fixation, supporting the bone and creating favorable conditions for optimal healing. This method is commonly preferred for fractures that are too unstable for traditional casting or external fixation techniques. Intramedullary nailing stands as a pivotal technique in orthopedic fracture management by promoting accelerated healing, minimizing discomfort, and enabling early movement of the affected limb. Manufacturers are focusing on developing intramedullary nails using materials such as titanium alloys, which offer superior strength, biocompatibility, and corrosion resistance compared to traditional materials like stainless steel. These advanced materials offer better implant longevity and also reduce the risk of adverse reactions and complications. Accordingly, the rise in adoption of advanced materials and technologies to enhance surgical outcomes and patient experience is a key trend for the growth of the Global Intramedullary Nails Market.

The global intramedullary nails market growth is being driven by the key factors such as the rising advantages provided by intramedullary nails plating, the growing availability of a diverse range of intramedullary nails in various sizes, favorable health reimbursement policies, and an increase in the occurrence of birth deformities affecting the femur, humerus, and tibia in children. The increasing prevalence of orthopedic injuries, including fractures of long bones like femur, tibia, and humerus, is a major driving force for the intramedullary nails market. These devices are crucial in stabilizing and promoting healing in such fractures. Furthermore, the rising elderly population is expected to drive the growth of the intramedullary nails market. Additionally, the rising development of intramedullary nails that are compatible with MRI and CT scans is anticipated to further stimulate market growth throughout the forecast period. However, lack of skilled professionals, along with availability of alternative treatment options is anticipated to stifle market growth between 2022 and 2032.

The key regions considered for the global Intramedullary Nails Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America is expected to maintain its leading position in terms of market revenue in the global intramedullary nails market owing to the surge in demand of intramedullary nails, rising instances of orthopedic injuries, and a widespread acceptance of orthopedic implants. Many orthopedic trauma and reconstruction device companies have experienced positive outcomes because of supportive regulatory approvals in the region. For instance, Globus Medical, Inc., a U.S.-based firm, obtained more than eighty-two FDA product approvals. Additionally, increasing collaborations between government bodies and private associations, has significantly contributed to market expansion. For instance, In October 2021, ExsoMed Corporation, a privately held medical device firm located in the United States that specializes in orthopedic solutions for hand surgery, announced that 10,000 metacarpal fractures had been successfully treated with the INnate Intramedullary Threaded Nail. This accomplishment has been made attainable in large part by the INnate nail, which is designed for minimally invasive fixing of metacarpal fractures.

Major market player included in this report are:

  • B. Braun Melsungen AG (Germany)
  • Orthofix Holdings, Inc. (United States)
  • Advanced Orthopaedic Solutions (United States)
  • Stryker (United States)
  • Smith+Nephew (United Kingdom)
  • Aysam Ortopedi & Tibbi Cihazlar (Turkey)
  • Wright Medical Group N.V. (Netherlands)
  • Zimmer Biomet (United States)
  • Johnson & Johnson Inc. (United States)
  • Pega Medical Inc (Canada)

The detailed segments and sub-segment of the market are explained below:

By Material

  • Stainless Steel
  • Titanium

By Product Type

  • Upper Bone Extremities
  • Lower Bone Extremities

By Application

  • Femoral Intramedullary nail
  • Tibial Intramedullary Nail
  • Gamma Intramedullary Nail
  • Others

By End-user

  • Hospitals
  • Specialty clinics
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1.Global Intramedullary Nails Market Definition and Research Assumptions

  • 1.1.Research Objective
  • 1.2.Market Definition
  • 1.3.Research Assumptions
    • 1.3.1.Inclusion & Exclusion
    • 1.3.2.Limitations
    • 1.3.3.Supply Side Analysis
      • 1.3.3.1.Availability
      • 1.3.3.2.Infrastructure
      • 1.3.3.3.Regulatory Environment
      • 1.3.3.4.Market Competition
      • 1.3.3.5.Economic Viability (Consumer's Perspective)
    • 1.3.4.Demand Side Analysis
      • 1.3.4.1.Regulatory frameworks
      • 1.3.4.2.Technological Advancements
      • 1.3.4.3.Environmental Considerations
      • 1.3.4.4.Consumer Awareness & Acceptance
  • 1.4.Estimation Methodology
  • 1.5.Years Considered for the Study
  • 1.6.Currency Conversion Rates

Chapter 2.Executive Summary

  • 2.1.Global Intramedullary Nails Market Size & Forecast (2022- 2032)
  • 2.2.Regional Summary
  • 2.3.Segmental Summary
    • 2.3.1.By Material
    • 2.3.2.By Product Type
    • 2.3.3.By Application
    • 2.3.4.By End-user
  • 2.4.Key Trends
  • 2.5.Recession Impact
  • 2.6.Analyst Recommendation & Conclusion

Chapter 3.Global Intramedullary Nails Market Dynamics

  • 3.1.Market Drivers
  • 3.2.Market Challenges
  • 3.3.Market Opportunities

Chapter 4.Global Intramedullary Nails Market: Industry Analysis

  • 4.1.Porter's 5 Force Model
    • 4.1.1.Bargaining Power of Suppliers
    • 4.1.2.Bargaining Power of Buyers
    • 4.1.3.Threat of New Entrants
    • 4.1.4.Threat of Substitutes
    • 4.1.5.Competitive Rivalry
    • 4.1.6.Futuristic Approach to Porter's 5 Force Model
    • 4.1.7.Porter's 5 Force Impact Analysis
  • 4.2.PESTEL Analysis
    • 4.2.1.Political
    • 4.2.2.Economic
    • 4.2.3.Social
    • 4.2.4.Technological
    • 4.2.5.Environmental
    • 4.2.6.Legal
  • 4.3.Top investment opportunity
  • 4.4.Top winning strategies
  • 4.5.Disruptive Trends
  • 4.6.Industry Expert Perspective
  • 4.7.Analyst Recommendation & Conclusion

Chapter 5.Global Intramedullary Nails Market Size & Forecasts by Material 2022-2032

  • 5.1.Stainless Steel
  • 5.2.Titanium

Chapter 6.Global Intramedullary Nails Market Size & Forecasts by Product Type 2022-2032

  • 6.1.Upper Bone Extremities
  • 6.2.Lower Bone Extremities

Chapter 7.Global Intramedullary Nails Market Size & Forecasts by Application 2022-2032

  • 7.1.Femoral Intramedullary nail
  • 7.2.Tibial Intramedullary Nail
  • 7.3.Gamma Intramedullary Nail
  • 7.4.Others

Chapter 8.Global Intramedullary Nails Market Size & Forecasts by End-user 2022-2032

  • 8.1.Hospitals
  • 8.2.Specialty clinics
  • 8.3.Others

Chapter 9.Global Intramedullary Nails Market Size & Forecasts by Region 2022-2032

  • 9.1.North America Intramedullary Nails Market
    • 9.1.1.U.S. Intramedullary Nails Market
      • 9.1.1.1. Material breakdown size & forecasts, 2022-2032
      • 9.1.1.2.Product Type breakdown size & forecasts, 2022-2032
      • 9.1.1.3.Application breakdown size & forecasts, 2022-2032
      • 9.1.1.4.End-user breakdown size & forecasts, 2022-2032
    • 9.1.2.Canada Intramedullary Nails Market
  • 9.2.Europe Intramedullary Nails Market
    • 9.2.1.U.K. Intramedullary Nails Market
    • 9.2.2.Germany Intramedullary Nails Market
    • 9.2.3.France Intramedullary Nails Market
    • 9.2.4.Spain Intramedullary Nails Market
    • 9.2.5.Italy Intramedullary Nails Market
    • 9.2.6.Rest of Europe Intramedullary Nails Market
  • 9.3.Asia-Pacific Intramedullary Nails Market
    • 9.3.1.China Intramedullary Nails Market
    • 9.3.2.India Intramedullary Nails Market
    • 9.3.3.Japan Intramedullary Nails Market
    • 9.3.4.Australia Intramedullary Nails Market
    • 9.3.5.South Korea Intramedullary Nails Market
    • 9.3.6.Rest of Asia Pacific Intramedullary Nails Market
  • 9.4.Latin America Intramedullary Nails Market
    • 9.4.1.Brazil Intramedullary Nails Market
    • 9.4.2.Mexico Intramedullary Nails Market
    • 9.4.3.Rest of Latin America Intramedullary Nails Market
  • 9.5.Middle East & Africa Intramedullary Nails Market
    • 9.5.1. Saudi Arabia Intramedullary Nails Market
    • 9.5.2. South Africa Intramedullary Nails Market
    • 9.5.3.Rest of Middle East & Africa Intramedullary Nails Market

Chapter 10.Competitive Intelligence

  • 10.1.Key Company SWOT Analysis
  • 10.2.Top Market Strategies
  • 10.3.Company Profiles
    • 10.3.1.B. Braun Melsungen AG (Germany)
      • 10.3.1.1.Key Information
      • 10.3.1.2.Overview
      • 10.3.1.3.Financial (Subject to Data Availability)
      • 10.3.1.4.Product Summary
      • 10.3.1.5.Market Strategies
    • 10.3.2.Orthofix Holdings, Inc. (United States)
    • 10.3.3.Advanced Orthopaedic Solutions (United States)
    • 10.3.4.Stryker (United States)
    • 10.3.5.Smith+Nephew (United Kingdom)
    • 10.3.6.Aysam Ortopedi & Tibbi Cihazlar (Turkey)
    • 10.3.7.Wright Medical Group N.V. (Netherlands)
    • 10.3.8.Zimmer Biomet (United States)
    • 10.3.9.Johnson & Johnson Inc. (United States)
    • 10.3.10.Pega Medical Inc (Canada)

Chapter 11.Research Process

  • 11.1.Research Process
    • 11.1.1.Data Mining
    • 11.1.2.Analysis
    • 11.1.3.Market Estimation
    • 11.1.4.Validation
    • 11.1.5.Publishing
  • 11.2.Research Attributes
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦